The Neurologist: Clinical & Therapeutics Journal
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Short Communication   
  • Neurol Clin Therapeut J 2023, Vol 7(5): 167
  • DOI: 10.4172/nctj.1000167

Which Are those Included in Neurology Data Sources

Dhondt Ortibus*
Department of Psychology, City University of Seattle in Canada, Edmonton, Canada
*Corresponding Author: Dhondt Ortibus, Department of Psychology, City University of Seattle in Canada, Edmonton, Canada, Email: Ortibusdhondt255@gmail.com

Received: 05-Sep-2023 / Manuscript No. nctj-23-114379 / Editor assigned: 07-Sep-2023 / PreQC No. nctj-23-114379 / Reviewed: 20-Sep-2023 / QC No. nctj-23-114379 / Revised: 23-Sep-2023 / Manuscript No. nctj-23-114379 / Accepted Date: 28-Sep-2023 / Published Date: 29-Sep-2023 DOI: 10.4172/nctj.1000167 QI No. / nctj-23-114379

Abstract

The field of neurology relies heavily on a wealth of data sources to advance our understanding of the intricate workings of the nervous system, diagnose disorders, and develop effective treatments. This abstract delves into the diverse range of data sources that contribute to the expansive landscape of neurology research and clinical practice. It highlights the critical role played by these sources in shaping the future of neurology and enhancing patient care. Neurology, as a multifaceted discipline, demands a robust foundation of data for both research and clinical purposes. Neurologists and researchers draw insights from a wide array of data sources, encompassing clinical records, neuroimaging, genetics, and wearable devices, among others. This investigation delves into the comprehensive spectrum of neurology data sources, shedding light on their individual contributions and their interconnectedness. Clinical data sources, such as electronic health records (EHRs), offer a treasure trove of patient information, facilitating accurate diagnosis and treatment planning. Neuroimaging data, including MRI, CT scans, and PET scans, provide invaluable glimpses into the brain’s structure and function, aiding in the identification of neurological conditions. Genomic data sources, in the form of large-scale genetic studies and biobanks, have revolutionized our understanding of the genetic underpinnings of neurological diseases. Moreover, wearable devices and patient-reported data play an increasingly prominent role in monitoring disease progression and treatment efficacy.

Keywords

Neurology; Data sources; Clinical records; Electronic health records (EHRs); Neuroimaging; MRI; CT scans; PET scans; Genomic data; Genetic studies; Biobanks; Wearable devices; Patientreported data; Artificial intelligence (AI); Machine learning; Precision medicine; Biomarkers; Diagnostic criteria

Introduction

Neurology, as a field at the forefront of medical science, relies on a rich tapestry of data sources to unravel the mysteries of the nervous system, diagnose complex disorders, and pave the way for innovative treatments. This introduction sets the stage for our exploration into the diverse and interconnected data sources that underpin the world of neurology, offering vital insights into the past, present, and future of this dynamic discipline.

Neurology is a multifaceted branch of medicine [1-5] dedicated to understanding the intricate complexities of the nervous system. In this endeavor, the acquisition, analysis, and interpretation of data are paramount. Neurologists and researchers alike draw upon an expansive array of data sources that collectively form the backbone of their work, spanning clinical records, advanced neuroimaging techniques, genomics, wearable devices, and emerging technologies. This investigation embarks on a comprehensive journey through the landscape of neurology data sources, illuminating their individual significance and the synergy they create within the field. Clinical data sources, epitomized by electronic health records (EHRs), harbor a treasure trove of patient information, serving as a cornerstone for accurate diagnosis and personalized treatment planning. Neuroimaging data, encompassing MRI, CT scans, and PET scans, provides [6] windows into the brain’s structure and function, guiding clinicians in the detection and characterization of neurological conditions.

Genomic data sources, comprising large-scale genetic studies and biobanks, have revolutionized our comprehension of the genetic underpinnings of neurological diseases, paving the way for targeted therapies and precision medicine. Meanwhile, wearable devices and patient-reported data have ushered in a new era of remote monitoring, enabling real-time tracking of disease progression and the evaluation of treatment efficacy.

As the field of neurology continues to advance, these data sources evolve in tandem. The advent of artificial intelligence (AI) and machine learning heralds a data-driven revolution, with these technologies analyzing vast datasets to uncover novel biomarkers, refine diagnostic criteria, and customize treatments to the individual patient.

As the field of neurology continues to advance, these data sources evolve in tandem. The advent of artificial intelligence (AI) and machine learning heralds a data-driven revolution, with these technologies analyzing vast datasets to uncover novel biomarkers, refine diagnostic criteria, and customize treatments to the individual patient.

Conclusion

The mosaic of data sources within neurology is a testament to the discipline’s progress and innovation. These interconnected sources, from clinical records to genomics and beyond, serve as the lifeblood of neurology’s evolution. As we embrace data-driven approaches, we move closer to a future where neurological disorders are not only better understood but also more accurately diagnosed and effectively treated, offering hope and improved quality of life to countless patients and their families.

References

  1. Hepler CD (1988) Unresolved issues in the future of pharmacy. Am J Hosp Pharm 45:1071-1081.
  2. Indexed at, Google Scholar

  3. Glassman PM, Balthasar JP (2019) Physiologically-based modeling of monoclonal antibody pharmacokinetics in drug discovery and development. Drug Metab Pharmacokinet 34:3-13.
  4. Indexed at, Google Scholar, Crossref

  5. Wang Y, Zhu H, Madabushi R, Liu Q, Huang SM, et al. (2019) Model‐informed drug development: current US regulatory practice and future considerations. Clin Pharmacol Ther 105:899-911
  6. Indexed at Google Scholar, Crossref

  7. Daubner J, Arshaad MI, Henseler C, Hescheler J, Ehninger D, et al.(2021) Pharmacological neuroenhancement: current aspects of categorization epidemiology pharmacology drug development ethics and future perspectives. Neural Plast :8823383
  8. Indexed at, Google Scholar, Crossref

  9. Abramo (2021) Future directions in specialty pharmacy. Am J Hosp Pharm 78:43-44.
  10. Löscher W (2017) Animal models of seizures and epilepsy: past, present, and future role for the discovery of antiseizure drugs. Neurochem Res 42:1873-1888.
  11. Indexed at, Google Scholar, Crossref

Citation: Ortibus D (2023) Which Are those Included in Neurology Data Sources. Neurol Clin Therapeut J 7: 167. DOI: 10.4172/nctj.1000167

Copyright: © 2023 Ortibus D. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top